Genetic polymorphisms of the lymphotoxin alpha gene are associated with increased risk for lethal infections during induction therapy for childhood acute leukemia: A case-control study

International Journal of Hematology

Volumn 89, Issue 5, 2009, Pages 584-591

  Kidas, Ekaterini ^a   Möricke, Anja ^b   Beier, Rita ^a   Welte, Karl ^a   Schrappe, Martin ^b   Stanulla, Martin ^a   Grigull, Lorenz ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Childhood; Genetic; Infection; Leukemia; Polymorphism

Indexed keywords

ANTILEUKEMIC AGENT; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLELE; ARTICLE; BACTERIAL INFECTION; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE AMPLIFICATION; GENOTYPE; HAPLOTYPE; HUMAN; INFANT; INFECTION RISK; MALE; MYCOSIS; POPULATION GENETICS; PRESCHOOL CHILD; SCHOOL CHILD; VIRUS INFECTION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFECTION; LYMPHOTOXIN-ALPHA; MALE; POLYMORPHISM, GENETIC; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK;

EID: 67749092925     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-009-0285-6     Document Type: Article

References (27)

1. I Hann C Viscoli M Paesmans H Gaya M Glauser 1997 A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC) Br J Haematol 99 580 588 10.1046/j.1365-2141.1997.4453255.x
2. L Grigull R Beier A Schrauder P Kirschner L Loening T Jack 2003 Invasive fungal infections are responsible for one-fifth of the infectious deaths in children with ALL Mycoses 46 441 446 10.1046/j.0933-7407.2003.00931.x (Pubitemid 38005338)
3. C Rossi J Klastersky 1996 Initial empirical antibiotic therapy for neutropenic fever: analysis of the causes of death Support Care Cancer 4 207 212 10.1007/BF01682342
4. S Ashkenazi L Leibovici Z Samra H Konisberger M Drucker 1992 Risk factors for mortality due to bacteremia and fungemia in childhood Clin Infect Dis 14 949 951
5. T Lehrnbecher SJ Chanock 1998 Controversies in the treatment of neutropenia in cancer patients Curr Opin Hematol 5 26 32 10.1097/00062752- 199801000-00005
6. MS Christensen M Heyman M Möttönen B Zeller G Jonmundsson H Hasle 2005 Nordic Society of Paediatric Haematology and Oncology (NOPHO). Treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992-2001 Br J Haematol 131 50 58 10.1111/j.1365-2141.2005.05736.x (Pubitemid 43899707)
7. G Waterer MW Quasney RM Cantor RG Wunderink 2001 Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations Am J Respir Crit Care Med 163 1599 1604
8. GJ Tang SL Huang HW Yien WS Chen CW Chi CW Wu 2000 Tumor necrosis factor gene polymorphism and septic shock in surgical infection Crit Care Med 28 2733 2736 10.1097/00003246-200008000-00008
9. JH Weitkamp F Stuber P Bartmann 2000 Pilot study assessing TNF gene polymorphism as a prognostic marker for disease progression in neonates with sepsis Infection 28 92 96 10.1007/s150100050053 (Pubitemid 30189614)
10. K Warzocha J Bienvenu B Coiffier G Salles 1995 Mechanism of action of the tumor necrosis factor and lymphotoxin ligand-receptor system Eur Cytokine Netw 6 83 96
11. F Bazzoni B Beutler 1996 The tumor necrosis factor ligand and receptor families N Engl J Med 334 1717 1725 10.1056/NEJM199606273342607 (Pubitemid 26193625)
12. AG Wilson FS di Giovine AIF Blakemore GW Duff 1992 Single base polymorphism in the human tumor necrosis factor alpha (TNFα) gene detectable by NcoI restriction of PCR product Hum Mol Genet 1 353 10.1093/hmg/1.5.353
13. AG Wilson FS di Giovine GW Duff 1995 Genetics of tumor necrosis factor-α in autoimmune, infectious, and neoplastic diseases J Inflamm 45 1 12
14. O Appoloni E Dupont M Vandercruys M Andriens J Duchateau JL Vincent 2001 The association of tumor necrosis factor-2 allele with plasma tumor necrosis factor-alpha levels and mortality from septic shock Am J Med 110 486 488 10.1016/S0002-9343(01)00656-8 (Pubitemid 32452337)
15. JP Mira A Cariou F Grall C Delclaux MR Losser F Heshmati 1999 Association of TNF2, a TNF-[alpha] promoter polymorphism, with septic shock susceptibility and mortality JAMA 282 561 568 10.1001/jama.282.6.561 (Pubitemid 29380293)
16. J Schroder V Kahlke M Book F Stuber 2000 Gender differences in sepsis: genetically determined? Shock 14 307 313 10.1097/00024382-200014030-00011
17. G Messer U Spengler MC Jung G Honold K Blömer GR Pape 1991 Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production J Exp Med 173 209 219 10.1084/jem.173.1.209
18. S Nadel MJ Newport R Booy M Levin 1996 Variation in the tumor necrosis factor-α gene promoter region may be associated with death from meningococcal disease J Infect Dis 174 878 880
19. F Stueber M Petersen F Bokelmami U Schade 1996 A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis Crit Care Med 24 381 384 10.1097/00003246-199603000-00004 (Pubitemid 26097828)
20. A Moericke A Reiter M Zimmermann H Gadner M Stanulla M Doerdelmann 2008 Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95 Blood 111 9 4477 4489 10.1182/blood-2007-09-112920
21. M Stanulla M Schrappe AM Brechlin M Zimmermann K Welte 2000 Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study Blood 95 1222 1228
22. K Warzocha P Ribeiro N Renard J Bienvenu C Charlot B Coiffier 1998 Plasma levels of tumor necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patients Br J Cancer 77 2357 2362
23. B Goldstein B Giroir A Randolph 2005 International consensus conference on pediatric sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics Pediatr Crit Care Med 6 1 2 8 10.1097/01.PCC.0000149131.72248.E6 (Pubitemid 40956461)
24. J Demeter F Porzsolt S Rämisch D Schmidt M Schmid G Messer 1997 Polymorphism of the tumour necrosis factor-alpha and lymphotoxin-alpha genes in chronic lymphocytic leukaemia Br J Haematol 97 107 112 10.1046/j.1365-2141.1997. 9912636.x (Pubitemid 27179570)
25. B Lausen K Schmiegelow B Andreassen HO Madsen P Garred 2006 Infections during induction therapy of childhood acute lymphoblastic leukemia-no association to mannose-binding lectin deficiency Eur J Haematol 76 481 487 10.1111/j.1600-0609.2006.00632.x
26. JA McArthur Q Zhang MW Quasney 2002 Association between the A/A genotype at the lymphotoxin-alpha +250 site and increased mortality in children with positive blood cultures Pediatr Crit Care Med 3 341 344 10.1097/00130478- 200210000-00002
27. M Schrappe A Reiter WD Ludwig J Harbott M Zimmermann W Hiddemann 2000 Improved outcome in childhood ALL despite reduced use of anthracyclines and of cranial radiotherapy: results of trial ALL-BFM 90 Blood 95 3310 3322